APA (7th ed.) Citation

Chen, C., Kao, Y., Yang, P., Chen, P., Yang, C., Li, W., . . . Lai, H. Elevated MS4A12 expression is indicative of resistance to concurrent chemoradiotherapy and inferior survival in patients with rectal cancer. BMC.

Chicago Style (17th ed.) Citation

Chen, Chih-I, Yi-Kai Kao, Po-Wen Yang, Pin-Chun Chen, Ching-Chieh Yang, Wan-Shan Li, Hsin-Hwa Tsai, Yu-Jen Wang, and Hong-Yue Lai. Elevated MS4A12 Expression Is Indicative of Resistance to Concurrent Chemoradiotherapy and Inferior Survival in Patients with Rectal Cancer. BMC.

MLA (9th ed.) Citation

Chen, Chih-I, et al. Elevated MS4A12 Expression Is Indicative of Resistance to Concurrent Chemoradiotherapy and Inferior Survival in Patients with Rectal Cancer. BMC.